Dataset Information

Total breast reconstruction with lipofilling after traditional mastectomy without the use of tissue expanders.

ABSTRACT:

Background

Lipofilling can be used to reconstruct a breast without additional implants or autologous composite grafts. However, methods to maximize retention of the transferred fat remain under debate. Here we present our experience of breast reconstruction with lipofilling without concomitant use of tissue expanders.

Methods

Patients who had completed breast reconstruction with lipofilling between June 2010 and June 2016 were reviewed. Those with obtainable follow-up MRI imaging were included in this cross-sectional study. The hospital records were reviewed for details of the lipofilling operations. MRI images were evaluated for the volume retention and quality of the transferred fat. The patients were asked to assess the appearance and sensitivity of the reconstructed breast, the recovery time, and any adverse effects at the fat donor area.

Results

38 women with 41 reconstructed breasts were included in the study. The median age at follow-up was 62 (range 48-78). They had undergone a median 4 (2-6) lipofilling procedures with a median total volume 690 (369-1350)ml. After a median 2.1 (0.4-6.8) year follow-up, the median proportion of transferred fat retained was 58 (14-119)%, representing reconstructed breast volume 76 (17-100)% of the contralateral breast. Oil cysts larger than 10mm were detected in 7%. Most patients reported being satisfied with the reconstructed breast and experienced few side effects.

Conclusions

Breast reconstruction with lipofilling can be performed with an acceptable number of procedures and no preoperative skin expansion. It extends the option of autologous breast reconstruction to women unsuitable for major reconstructive procedures.

SUBMITTER: Homsy P

PROVIDER: S-EPMC10461718 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Total Breast Reconstruction with Lipofilling after Traditional Mastectomy without the Use of Tissue Expanders.

Homsy Pauliina P Höckerstedt Anna A Hukkinen Katja K Kauhanen Susanna S

Plastic and reconstructive surgery 20230214 3

<h4>Background</h4>Lipofilling can be used to reconstruct a breast without additional implants or autologous composite grafts. However, methods to maximize retention of the transferred fat remain under debate. Here, the authors present their experience of breast reconstruction with lipofilling without concomitant use of tissue expanders.<h4>Methods</h4>Patients who had completed breast reconstruction with lipofilling between June of 2010 and June of 2016 were reviewed. Those with obtainable foll ...[more]

PMID: 36780348

Similar Datasets

Project description:BackgroundProphylactic antibiotics are commonly prescribed at discharge for mastectomy, despite guidelines recommending against this practice. We investigated factors associated with postdischarge prophylactic antibiotic use after mastectomy with and without immediate reconstruction and the impact on surgical-site infection (SSI).Study designWe studied a cohort of women aged 18-64 years undergoing mastectomy between January 1, 2010, and June 30, 2015, using the MarketScan commercial database. Patients with nonsurgical perioperative infections were excluded. Postdischarge oral antibiotics were identified from outpatient drug claims. SSI was defined using International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) diagnosis codes. Generalized linear models were used to determine factors associated with postdischarge prophylactic antibiotic use and SSI.ResultsThe cohort included 38,793 procedures; 24,818 (64%) with immediate reconstruction. Prophylactic antibiotics were prescribed after discharge after 2,688 mastectomy-only procedures (19.2%) and 17,807 mastectomies with immediate reconstruction (71.8%). The 90-day incidence of SSI was 3.5% after mastectomy only and 8.8% after mastectomy with immediate reconstruction. Antibiotics with anti-methicillin-sensitive Staphylococcus aureus (MSSA) activity were associated with decreased SSI risk after mastectomy only (adjusted relative risk [aRR], 0.74; 95% confidence interval [CI], 0.55-0.99) and mastectomy with immediate reconstruction (aRR, 0.80; 95% CI, 0.73-0.88), respectively. The numbers needed to treat to prevent 1 additional SSI were 107 and 48, respectively.ConclusionsPostdischarge prophylactic antibiotics were common after mastectomy. Anti-MSSA antibiotics were associated with decreased risk of SSI for patients who had mastectomy only and those who had mastectomy with immediate reconstruction. The high numbers needed to treat suggest that potential benefits of postdischarge antibiotics should be weighed against potential harms associated with antibiotic overuse.